Increased Risk Of Marked Hepatic Enzyme Elevations In Patients Taking Somavert (pegvisomant) In Combination With A Somatostatin Analogue - For Health Professionals

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2008-06-10

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/4cee396b-a17e-4d0b-b635-bcd60bea2f97